AU Stock MarketDetailed Quotes

PAAOA Neurizon Therapeutics Ltd

Watchlist
  • 0.120
  • 0.0000.00%
20min DelayMarket Closed Oct 14 16:00 AET
58.40MMarket Cap0.00P/E (Static)

Neurizon Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
-16.48%2.82M
57.98%3.38M
-33.03%2.14M
-12.93%3.2M
3.67M
Operating revenue
----
-16.48%2.82M
57.98%3.38M
-33.03%2.14M
-12.93%3.2M
--3.67M
Cost of revenue
150.53%787.54K
39.51%314.34K
-8.47%225.32K
-26.22%246.16K
333.63K
Gross profit
-33.60%2.04M
60.15%3.07M
-35.08%1.92M
-11.60%2.95M
3.34M
Operating expense
16.07%6.66M
-1.36%5.74M
23.58%5.82M
-8.09%4.71M
-7.47%5.12M
5.53M
Selling and administrative expenses
-34.66%2.81M
-9.32%4.3M
23.11%4.74M
-9.16%3.85M
-1.90%4.24M
--4.32M
-General and administrative expense
-34.66%2.81M
-9.32%4.3M
23.11%4.74M
-9.16%3.85M
-1.90%4.24M
--4.32M
Research and development costs
272.85%3.85M
35.99%1.03M
36.91%758.66K
-8.46%554.14K
-41.74%605.35K
--1.04M
Depreciation amortization depletion
-99.50%1.64K
3.69%326.55K
4.99%314.93K
9.22%299.97K
59.27%274.64K
--172.43K
-Depreciation and amortization
-99.50%1.64K
3.69%326.55K
4.99%314.93K
9.22%299.97K
59.27%274.64K
--172.43K
Provision for doubtful accounts
----
--77.98K
----
----
----
----
Operating profit
-79.93%-6.66M
-34.61%-3.7M
1.51%-2.75M
-28.57%-2.79M
1.21%-2.17M
-2.2M
Net non-operating interest income (expenses)
3,023.30%24.47K
99.05%-837
-36.89%-87.98K
44.21%-64.27K
-283.71%-115.21K
-30.02K
Non-operating interest income
-69.80%24.47K
15,016.60%81.03K
-96.36%536
347.36%14.72K
-81.51%3.29K
--17.8K
Non-operating interest expense
----
-7.51%81.86K
12.06%88.51K
-33.34%78.99K
147.78%118.5K
--47.82K
Other net income (expenses)
9.73%-2.27M
-322.35%-2.51M
-25.56%1.13M
64.09%1.52M
36.66%924.23K
676.3K
Special income (charges)
11.35%-3.11M
---3.51M
----
----
----
----
-Less:Impairment of capital assets
-11.35%3.11M
--3.51M
----
----
----
----
Other non-operating income (expenses)
-15.44%841.71K
-11.83%995.37K
-25.56%1.13M
64.09%1.52M
36.66%924.23K
--676.3K
Income before tax
-43.28%-8.9M
-263.63%-6.21M
-27.73%-1.71M
1.81%-1.34M
12.20%-1.36M
-1.55M
Income tax
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
-23.53%-7.67M
-263.63%-6.21M
-27.73%-1.71M
1.81%-1.34M
12.20%-1.36M
-1.55M
Net income continuous operations
-43.28%-8.9M
-263.63%-6.21M
-27.73%-1.71M
1.81%-1.34M
12.20%-1.36M
---1.55M
Net income discontinuous operations
--1.23M
----
----
----
----
----
Noncontrolling interests
Net income attributable to the company
-23.53%-7.67M
-263.63%-6.21M
-27.73%-1.71M
1.81%-1.34M
12.20%-1.36M
-1.55M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-23.53%-7.67M
-263.63%-6.21M
-27.73%-1.71M
1.81%-1.34M
12.20%-1.36M
-1.55M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue -16.48%2.82M57.98%3.38M-33.03%2.14M-12.93%3.2M3.67M
Operating revenue -----16.48%2.82M57.98%3.38M-33.03%2.14M-12.93%3.2M--3.67M
Cost of revenue 150.53%787.54K39.51%314.34K-8.47%225.32K-26.22%246.16K333.63K
Gross profit -33.60%2.04M60.15%3.07M-35.08%1.92M-11.60%2.95M3.34M
Operating expense 16.07%6.66M-1.36%5.74M23.58%5.82M-8.09%4.71M-7.47%5.12M5.53M
Selling and administrative expenses -34.66%2.81M-9.32%4.3M23.11%4.74M-9.16%3.85M-1.90%4.24M--4.32M
-General and administrative expense -34.66%2.81M-9.32%4.3M23.11%4.74M-9.16%3.85M-1.90%4.24M--4.32M
Research and development costs 272.85%3.85M35.99%1.03M36.91%758.66K-8.46%554.14K-41.74%605.35K--1.04M
Depreciation amortization depletion -99.50%1.64K3.69%326.55K4.99%314.93K9.22%299.97K59.27%274.64K--172.43K
-Depreciation and amortization -99.50%1.64K3.69%326.55K4.99%314.93K9.22%299.97K59.27%274.64K--172.43K
Provision for doubtful accounts ------77.98K----------------
Operating profit -79.93%-6.66M-34.61%-3.7M1.51%-2.75M-28.57%-2.79M1.21%-2.17M-2.2M
Net non-operating interest income (expenses) 3,023.30%24.47K99.05%-837-36.89%-87.98K44.21%-64.27K-283.71%-115.21K-30.02K
Non-operating interest income -69.80%24.47K15,016.60%81.03K-96.36%536347.36%14.72K-81.51%3.29K--17.8K
Non-operating interest expense -----7.51%81.86K12.06%88.51K-33.34%78.99K147.78%118.5K--47.82K
Other net income (expenses) 9.73%-2.27M-322.35%-2.51M-25.56%1.13M64.09%1.52M36.66%924.23K676.3K
Special income (charges) 11.35%-3.11M---3.51M----------------
-Less:Impairment of capital assets -11.35%3.11M--3.51M----------------
Other non-operating income (expenses) -15.44%841.71K-11.83%995.37K-25.56%1.13M64.09%1.52M36.66%924.23K--676.3K
Income before tax -43.28%-8.9M-263.63%-6.21M-27.73%-1.71M1.81%-1.34M12.20%-1.36M-1.55M
Income tax 000000
Earnings from equity interest net of tax
Net income -23.53%-7.67M-263.63%-6.21M-27.73%-1.71M1.81%-1.34M12.20%-1.36M-1.55M
Net income continuous operations -43.28%-8.9M-263.63%-6.21M-27.73%-1.71M1.81%-1.34M12.20%-1.36M---1.55M
Net income discontinuous operations --1.23M--------------------
Noncontrolling interests
Net income attributable to the company -23.53%-7.67M-263.63%-6.21M-27.73%-1.71M1.81%-1.34M12.20%-1.36M-1.55M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -23.53%-7.67M-263.63%-6.21M-27.73%-1.71M1.81%-1.34M12.20%-1.36M-1.55M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data